These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 26902491

  • 1. Effects of Baroreflex Activation Therapy on Ambulatory Blood Pressure in Patients With Resistant Hypertension.
    Wallbach M, Lehnig LY, Schroer C, Lüders S, Böhning E, Müller GA, Wachter R, Koziolek MJ.
    Hypertension; 2016 Apr; 67(4):701-9. PubMed ID: 26902491
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT Neo system.
    Wallbach M, Born E, Kämpfer D, Lüders S, Müller GA, Wachter R, Koziolek MJ.
    Clin Res Cardiol; 2020 Apr; 109(4):513-522. PubMed ID: 31388741
    [Abstract] [Full Text] [Related]

  • 3. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.
    Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA.
    J Am Coll Cardiol; 2011 Aug 09; 58(7):765-73. PubMed ID: 21816315
    [Abstract] [Full Text] [Related]

  • 4. Baroreceptor stimulation for resistant hypertension: first implantation in France and literature review.
    Courand PY, Feugier P, Workineh S, Harbaoui B, Bricca G, Lantelme P.
    Arch Cardiovasc Dis; 2014 Dec 09; 107(12):690-6. PubMed ID: 25445751
    [Abstract] [Full Text] [Related]

  • 5. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.
    Illig KA, Levy M, Sanchez L, Trachiotis GD, Shanley C, Irwin E, Pertile T, Kieval R, Cody R.
    J Vasc Surg; 2006 Dec 09; 44(6):1213-1218. PubMed ID: 17145423
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.
    Tordoir JH, Scheffers I, Schmidli J, Savolainen H, Liebeskind U, Hansky B, Herold U, Irwin E, Kroon AA, de Leeuw P, Peters TK, Kieval R, Cody R.
    Eur J Vasc Endovasc Surg; 2007 Apr 09; 33(4):414-21. PubMed ID: 17227715
    [Abstract] [Full Text] [Related]

  • 8. The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT study.
    Gordin D, Fadl Elmula FEM, Andersson B, Gottsäter A, Elf J, Kahan T, Christensen KL, Vikatmaa P, Vikatmaa L, Bastholm Olesen T, Groop PH, Olsen MH, Tikkanen I, Nordic BAT Study Group.
    Blood Press; 2017 Oct 09; 26(5):294-302. PubMed ID: 28595464
    [Abstract] [Full Text] [Related]

  • 9. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.
    Alnima T, Scheffers I, De Leeuw PW, Winkens B, Jongen-Vancraybex H, Tordoir JH, Schmidli J, Mohaupt MG, Allemann Y, Kroon AA.
    J Hypertens; 2012 Aug 09; 30(8):1665-70. PubMed ID: 22728906
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
    Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD.
    J Am Soc Hypertens; 2012 Aug 09; 6(2):152-8. PubMed ID: 22341199
    [Abstract] [Full Text] [Related]

  • 12. Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension.
    Wallbach M, Zürbig P, Dihazi H, Müller GA, Wachter R, Beige J, Koziolek MJ, Mischak H.
    J Clin Hypertens (Greenwich); 2018 Oct 09; 20(10):1519-1526. PubMed ID: 30203514
    [Abstract] [Full Text] [Related]

  • 13. Acute on/off effects and chronic blood pressure reduction after long-term baroreflex activation therapy in resistant hypertension.
    Halbach M, Hickethier T, Madershahian N, Reuter H, Brandt MC, Hoppe UC, Müller-Ehmsen J.
    J Hypertens; 2015 Aug 09; 33(8):1697-703. PubMed ID: 26107267
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 15. Effects of carotid baroreceptor stimulation on retinal arteriole remodeling evaluated with adaptive optics camera in resistant hypertensive patients.
    Gallo A, Rosenbaum D, Kanagasabapathy C, Girerd X.
    Ann Cardiol Angeiol (Paris); 2017 Jun 09; 66(3):165-170. PubMed ID: 28554698
    [Abstract] [Full Text] [Related]

  • 16. Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.
    Alnima T, de Leeuw PW, Tan FE, Kroon AA, Rheos Pivotal Trial Investigators.
    Hypertension; 2013 Jun 09; 61(6):1334-9. PubMed ID: 23589562
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC, Ayala DE, Fernández JR, Mojón A.
    Chronobiol Int; 2013 Mar 09; 30(1-2):68-86. PubMed ID: 23181592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.